We are live on
!
Find out more
SCM
Sio Capital Management Portfolio holdings
AUM
$604M
1-Year Est. Return
96.57%
This Fund
S&P 500
This Quarter
Est. Return
-10.56%
1 Year Est. Return
+96.57%
3 Year Est. Return
+564.25%
5 Year Est. Return
+486.18%
10 Year Est. Return
+2,856.71%
AUM
$273M
AUM Growth
+$47.4M
(+21%)
Cap. Flow
+$32.7M
Cap. Flow
% of AUM
11.98%
Top 10 Holdings %
Top 10 Hldgs %
53.37%
Holding
60
New
18
Increased
13
Reduced
8
Closed
18
Avg Time Held Equity + Options
1.4
quarters
Top 10 Avg Time Held Equity + Options
0.8
quarters
Top 20 Avg Time Held Equity + Options
1.2
quarters
Avg Time Held Equity only
1.5
quarters
Top 10 Avg Time Held Equity only
0.8
quarters
Top 20 Avg Time Held Equity only
1.4
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$11.5M |
| 2 |
Cardinal Health
CAH
|
+$10.9M |
| 3 |
Eli Lilly
LLY
|
+$10.6M |
| 4 |
SHPG
Shire pic
SHPG
|
+$10.6M |
| 5 |
AGN
Allergan plc
AGN
|
+$10.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DYAX
DYAX CORPORATION
DYAX
|
+$25.9M |
| 2 |
Cigna
CI
|
+$7.15M |
| 3 |
CTIC
CTI BioPharma Corp. (DE) Common Stock
CTIC
|
+$6.51M |
| 4 |
Sanofi
SNY
|
+$6.32M |
| 5 |
AbbVie
ABBV
|
+$6.15M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 76.98% |
| 2 | Miscellaneous | 18.82% |
| 3 | Consumer Discretionary | 2.55% |
| 4 | Industrials | 1.65% |
| 5 | Financials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
PUT
Jazz Pharmaceuticals
JAZZ
$13.7B
| $32.3M | 11.82% |
+247,400
| New | +$30.8M |
2016 Q1
0 quarters
|
|
|
QTNT
2
DELISTED
Quotient Limited Ordinary Shares
QTNT
| $20.9M | 7.64% |
59,329
+14,600
| +33% | +$5.96M |
2014 Q4
5 quarters
|
|
|
NEOS
3
DELISTED
Neos Therapeutics, Inc
NEOS
| $13.9M | 5.09% |
1,290,023
+508,509
| +65% | +$5.36M |
2015 Q3
2 quarters
|
|
4
McKesson
MCK
$112B
| $13.1M | 4.81% |
83,600
+27,600
| +49% | +$4.46M |
2015 Q4
1 quarter
|
|
|
5
Amgen
AMGN
$223B
| $11.7M | 4.26% |
+77,721
| New | +$11.5M |
2016 Q1
0 quarters
|
|
|
ANTH
6
DELISTED
Anthera Pharmaceuticals, Inc.
ANTH
| $11.1M | 4.05% |
382,025
+209,720
| +122% | +$5.69M |
2015 Q2
3 quarters
|
|
|
7
Cardinal Health
CAH
$55.5B
| $11M | 4.04% |
+134,633
| New | +$10.9M |
2016 Q1
0 quarters
|
|
|
SHPG
8
DELISTED
Shire pic
SHPG
| $10.9M | 3.99% |
+63,411
| New | +$10.6M |
2016 Q1
0 quarters
|
|
9
PUT
Johnson & Johnson
JNJ
$599B
| $10.8M | 3.96% |
+100,000
| New | +$10.4M |
2016 Q1
0 quarters
|
|
|
10
Eli Lilly
LLY
$1.04T
| $10.1M | 3.7% |
+140,392
| New | +$10.6M |
2016 Q1
0 quarters
|
|
11
Alnylam Pharmaceuticals
ALNY
$29.9B
| $9.65M | 3.53% |
+153,778
| New | +$10.2M |
2016 Q1
0 quarters
|
|
|
AGN
12
DELISTED
Allergan plc
AGN
| $9.63M | 3.53% |
+35,937
| New | +$10.3M |
2016 Q1
0 quarters
|
|
13
United Therapeutics
UTHR
$23.3B
| $8.62M | 3.15% |
+77,317
| New | +$9.78M |
2016 Q1
0 quarters
|
|
|
14
Sanofi
SNY
$93.7B
| $8.22M | 3.01% |
204,655
-157,307
| -43% | -$6.32M |
2015 Q3
2 quarters
|
|
15
Philips
PHG
$24.3B
| $8M | 2.93% |
+391,574
| New | +$7.23M |
2016 Q1
0 quarters
|
|
|
DMK
16
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
| $7.74M | 2.83% |
18,033
-805
| -4% | -$288K |
2014 Q4
5 quarters
|
|
|
VSI
17
DELISTED
Vitamin Shoppe Inc.
VSI
| $6.96M | 2.55% |
224,668
-15,332
| -6% | -$461K |
2015 Q4
1 quarter
|
|
18
Novartis
NVS
$271B
| $6.88M | 2.52% |
+106,007
| New | +$7.21M |
2016 Q1
0 quarters
|
|
|
PFNX
19
DELISTED
Pfenex Inc.
PFNX
| $6.52M | 2.39% |
663,176
+215,914
| +48% | +$1.89M |
2014 Q4
5 quarters
|
|
20
DELISTED
Advanced Accelerator Applications S.A.
AAAP
| $6.09M | 2.23% |
174,001
-117,876
| -40% | -$3.53M |
2015 Q4
1 quarter
|
|
|
RXDX
21
DELISTED
Ignyta, Inc.
RXDX
| $5.45M | 2% |
805,327
+160,710
| +25% | +$1.32M |
2015 Q2
3 quarters
|
|
22
DELISTED
BioTelemetry, Inc.
BEAT
| $4.83M | 1.77% |
413,649
+221,894
| +116% | +$2.48M |
2015 Q4
1 quarter
|
|
23
TriNet
TNET
$3.06B
| $4.5M | 1.65% |
+313,675
| New | +$4.45M |
2016 Q1
0 quarters
|
|
|
FOMX
24
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
| $3.73M | 1.37% |
572,628
+156,656
| +38% | +$1.01M |
2015 Q2
3 quarters
|
|
|
FWP
25
DELISTED
Forward Pharma A/S American Depositary Shares
FWP
| $3.68M | 1.35% |
30,915
+16,629
| +116% | +$1.86M |
2015 Q4
1 quarter
|
|
Similar funds
EFL
V
MAM
RCM
AMG
VV
VCP
EHI
Sio Capital Management's Q1 2016 Portfolio in Review
As of Q1 2016, Sio Capital Management held 60 positions worth $273M, up 21% from $226M the previous quarter. Its ten largest holdings account for 53% of the portfolio.
Sio Capital Management deployed $32.7M of net new capital in Q1 2016, opening 18 new positions and adding to 13 existing holdings. Its largest new stake was Amgen: 77,721 shares worth $11.7M.
By sector, the portfolio is most concentrated in Healthcare at 77% of assets, down from 82% a quarter earlier, followed by Miscellaneous and Consumer Discretionary.
On the sell side, the largest reduction was Sanofi, an estimated $6.32M trimmed.
- Sio Capital Management's largest Q1 2016 buy was Amgen: 77,721 shares worth $11.7M.
- Sio Capital Management added most to Quotient Limited Ordinary Shares in Q1 2016, an estimated $5.96M increase.
- Sio Capital Management's biggest Q1 2016 reduction was Sanofi, cutting an estimated $6.32M.
- Sio Capital Management fully exited DYAX CORPORATION in Q1 2016, selling an estimated $25.9M.
- Sio Capital Management's ten largest holdings make up 53% of its $273M portfolio in Q1 2016.
- Sio Capital Management opened 18 new positions and closed 18 in Q1 2016.
- Sio Capital Management's portfolio value rose 21% quarter-over-quarter to $273M.
Based on Sio Capital Management's 13F filing for Q1 2016, filed 16 May 2016.